E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/29/2005 in the Prospect News Biotech Daily.

MannKind kept by Jefferies at underperform

MannKind Corp. was reiterated by Jefferies & Co. analyst Adam Walsh at an underperform rating at a price target of $6 per share following second-quarter results. MannKind shares Friday were down $0.19, or 2.16%, at $8.60 on volume of 170,732 shares versus the three-month running average of 162,274 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.